1. Use of frozen native feces for fecal microbiota transplantation in recurrent Clostridioides difficile infection: a simple way to improve the efficiency of donor feces preparation.
- Author
-
Sintes R, McLellan P, Navelli G, Landman C, Delage S, Truong S, Benech N, Kapel N, Moreino Sabater A, Schnuriger A, Eckert C, Bleibtreu A, Joly A-C, and Sokol H
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Recurrence, Freezing, Fecal Microbiota Transplantation methods, Feces microbiology, Clostridium Infections therapy, Clostridium Infections microbiology, Clostridioides difficile
- Abstract
Preparing fecal microbiota transplants immediately after donation is resource-intensive, and a proportion are destroyed following abnormal screening results. We retrospectively compared two processes, frozen fecal preparation (FFP) and fresh native frozen preparation (FNFP), for clinical efficacy in the treatment of recurrent Clostridioides difficile infection (rCDI). FFP and FNFP were similarly effective with clinical success rates of 76.7% and 86.7% ( P = 0.32), respectively. FNFP is an efficient procedure that saves resources while maintaining clinical efficacy in rCDI., Competing Interests: H.S. reports lecture fee, board membership, or consultancy from Amgen, Fresenius, IPSEN, Actial, Astellas, Danone, THAC, Biose, BiomX, Eligo, Immusmol, Adare, Nestle, Ferring, MSD, Bledina, Pfizer, Biocodex, BMS, Bromatech, Gilead, Janssen, Mayoli, Roche, Sanofi, Servier, Takeda, Abbvie, and Lilly, has stocks from Enterome bioscience, and is co-founder of Exeliom Biosciences.
- Published
- 2024
- Full Text
- View/download PDF